Bruker

BRKR

Current ValuationThe current P/E ratio is -85.12, within the reasonable range, cheaper than 72.92% of the time in the past 3 years, and the industry ranks 55/58, the industry Median -2.50.

-85.12xP/E
Stock price$59.72Earnings per share$-0.70

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-350.16x--$48.26B
CRLUSCharles River Laboratorie
-60.12x241.81%$14.34B
TEMUSTempus AI
-49.61x1.28%$12.62B
AVTRUSAvantor
-17.96x144.24%$10.38B
TXGUS10X Genomics
-131.98x107.28%$9.92B
BRKRUSBruker
-85.12x7.71%$9.10B
ADPTUSAdaptive Biotechnologies
-65.68x39.25%$4.19B
ABCLUSAbcellera Biologics
-25.25x36.73%$4.16B
FTREUSFortrea
-22.95x93.77%$1.96B
MRVIUSMaravai LifeSciences
-24.93x64.44%$1.93B
ALMRUSAlamar Biosciences
-38.80x80.55%$1.93B
PSNLUSPersonalis
-15.94x18.68%$1.71B
AZTAUSAzenta
-12.79x180.77%$1.57B
CYRXUSCryoport
-19.36x156.25%$878.76M
PACBUSPacific Biosc California
-6.43x75.69%$845.46M
DNAUSGinkgo Bioworks
-2.66x35.20%$772.39M
CTKBUSCytek Biosciences
-8.61x33.98%$694.11M
OABIUSOmniAb
-14.98x35.96%$662.98M
EVOUSEvotec SE
-2.50x375.28%$571.89M
TKNOUSAlpha Teknova
-27.89x5.80%$467.62M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.